Suppr超能文献

经皮冠状动脉介入治疗和血运重建术均可改善冠状动脉慢性完全闭塞(CTO)患者的预后,而与侧支循环的丰富程度无关。

Both surgical and percutaneous revascularization improve prognosis in patients with a coronary chronic total occlusion (CTO) irrespective of collateral robustness.

机构信息

Department of Cardiology, Royal North Shore Hospital, Reserve Rd, St. Leonards, Sydney, 2065, Australia.

The University of Sydney, Sydney, Australia.

出版信息

Heart Vessels. 2021 Nov;36(11):1653-1660. doi: 10.1007/s00380-021-01859-2. Epub 2021 Apr 29.

Abstract

The impact of surgical or percutaneous coronary revascularization on prognosis in patients with a chronic total occlusion (CTO) remains uncertain. Particularly, whether revascularization of those with robust coronary collaterals improves prognosis is unknown. The objective of this study was to determine the predictors and prognostic impact of revascularization of a CTO, and to determine the clinical impact of robust coronary collaterals. Patients with a CTO diagnosed on coronary angiography between Jul 2010 and Dec 2019 were included in this study. Management strategy of the CTO was defined as percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG) or medical management. The degree of collateral robustness was determined by the Rentrop grading classification. Demographic, angiographic and clinical outcomes were recorded. A total of 954 patients were included in the study, of which 186 (19.5%) patients underwent CTO PCI, 296 (31.0%) patients underwent CABG and 472 (49.5%) patients underwent medical management of the CTO. 166 patients (17.4%) had Rentrop grade zero or one collaterals, 577 (60.5%) patients had Rentrop grade two and 211 (22.1%) had Rentrop grade three collaterals. The independent predictors of medical management of the CTO were older age, greater stenosis in the donor vessel, an emergent indication for angiography, a non-LAD CTO and female sex. The degree of collateral robustness was not associated with long-term mortality, while patients who were revascularized either through CABG or PCI had a significantly lower mortality compared to medical management alone (p < 0.0001). In patients with a CTO, the presence of robust collaterals is not associated with prognosis, while both surgical and percutaneous revascularization is associated with improved prognosis. Further research into the optimal revascularization strategy for a CTO is required.

摘要

经皮冠状动脉血运重建或外科血运重建对慢性完全闭塞(CTO)患者预后的影响尚不确定。特别是,有丰富侧支循环的患者血运重建是否能改善预后尚不清楚。本研究的目的是确定 CTO 血运重建的预测因素和预后影响,并确定丰富侧支循环的临床影响。本研究纳入了 2010 年 7 月至 2019 年 12 月期间冠状动脉造影诊断为 CTO 的患者。CTO 的治疗策略定义为经皮冠状动脉介入治疗(PCI)、冠状动脉旁路移植术(CABG)或药物治疗。侧支循环丰富程度通过 Rentrop 分级分类确定。记录了人口统计学、血管造影和临床结果。共纳入 954 例患者,其中 186 例(19.5%)患者行 CTO PCI,296 例(31.0%)患者行 CABG,472 例(49.5%)患者行 CTO 药物治疗。166 例(17.4%)患者侧支循环 Rentrop 分级为 0 或 1 级,577 例(60.5%)患者侧支循环 Rentrop 分级为 2 级,211 例(22.1%)患者侧支循环 Rentrop 分级为 3 级。CTO 药物治疗的独立预测因素为年龄较大、供体血管狭窄程度较大、紧急行血管造影、非左前降支 CTO 和女性。侧支循环丰富程度与长期死亡率无关,而通过 CABG 或 PCI 进行血运重建的患者与单纯药物治疗相比死亡率显著降低(p<0.0001)。在 CTO 患者中,丰富的侧支循环与预后无关,而外科和经皮血运重建均与改善预后相关。需要进一步研究 CTO 的最佳血运重建策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验